Analyst desks were busy on Wednesday. Several significant rating and target price moves stand out from the latest data.
Pentair takes the biggest hit. PNR was downgraded by analysts, with the consensus target slipping to $88.27 from $90.80. The water treatment firm carries a $12.2 billion market cap. A downgrade here is notable — the stock had been a steady compounder.
Elevance Health saw conflicting moves. ELV received a target cut from one analyst, pushing the consensus to $445.81. A second desk raised its target earlier the same day. The divergence signals real uncertainty around the managed care giant amid ongoing Medicaid pressures.
Bank of New York Mellon got a lift. BNY analysts pushed the average target up to $160.79 from $156.57. The $106 billion custody bank has been a quiet beneficiary of rising rate volatility.
J.B. Hunt Transport also saw target upgrades. JBHT consensus moved to $287.29 from $284.76. Freight volumes appear to be stabilising.
Meanwhile, multiple medtech names — including , , and — had recommendations removed. That sweep suggests a broker restructuring its coverage rather than any stock-specific signal.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
